Statins may improve outcomes among cirrhotic patients with hepatitis B or C

Medications commonly prescribed to treat high cholesterol may improve outcomes among patients with cirrhosis linked to hepatitis C or B, according to a study published in the journal Hepatology.

For the study, researchers assessed health data for 1,350 cirrhotic patients compiled in a database of health insurance beneficiaries in Taiwan between 2000 and 2013. Statin use among these individuals was associated with a decreased likelihood of liver failure and mortality.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

"The study demonstrates a favorable outcome that should be re-confirmed by future prospective and large-scaled studies," said senior author Ching-Liang Lu, MD, a physician in the division of gastroenterology Veterans General Hospital, Taipei, Taiwan. "Moreover, future investigations should also explore whether the favorable effect of statin use can also be extended to cirrhosis due to other causes, such as alcohol."

More articles on infection control: 
New BMC primary care program for hepatitis C treatment shows promise 
2 Las Vegas schools closed amid possible norovirus outbreak 
90 unvaccinated California elementary school students asked to stay home amid chickenpox outbreak 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars